SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-22-003416
Filing Date
2022-11-14
Accepted
2022-11-14 17:03:43
Documents
53
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q eucr-20220930x10q.htm   iXBRL 10-Q 951785
2 EX-31.1 eucr-20220930xex31d1.htm EX-31.1 12711
3 EX-31.2 eucr-20220930xex31d2.htm EX-31.2 12560
4 EX-32.1 eucr-20220930xex32d1.htm EX-32.1 6314
5 EX-32.2 eucr-20220930xex32d2.htm EX-32.2 6324
  Complete submission text file 0001410578-22-003416.txt   4597682

Data Files

Seq Description Document Type Size
6 EX-101.SCH eucr-20220930.xsd EX-101.SCH 41918
7 EX-101.CAL eucr-20220930_cal.xml EX-101.CAL 18453
8 EX-101.DEF eucr-20220930_def.xml EX-101.DEF 150323
9 EX-101.LAB eucr-20220930_lab.xml EX-101.LAB 301011
10 EX-101.PRE eucr-20220930_pre.xml EX-101.PRE 240033
47 EXTRACTED XBRL INSTANCE DOCUMENT eucr-20220930x10q_htm.xml XML 819064
Mailing Address 250 WEST 55TH STREET, SUITE 13D NEW YORK NY 10019
Business Address 250 WEST 55TH STREET, SUITE 13D NEW YORK NY 10019 (212) 710-5220
Eucrates Biomedical Acquisition Corp. (Filer) CIK: 0001822929 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39650 | Film No.: 221387311
SIC: 6770 Blank Checks